Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015

키워드

참고문헌 (31)

1. Centers for Disease Control and Prevention, "Antibiotic resistance threat in the United States, 2013", Centers for Disease Control and Prevention, US Department of Health and Human Service, ~ (2013)
2. Hong SG, "Antimicrobial resistance of clinically important bacteria isolated from hospitals located in representative provinces of Korea", Korean J Clin Microbiol, 6, pp.29~36 (2003)
3. 이경원, "Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007", Yonsei Medical Journal, 51(6), pp.901~911 (2010), 연세대학교의과대학
4. 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
5. Lee Y, "Clonality and resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing", Biomed Res Int, 2014, pp.352862~ (2014)
6. O’Brien TF, "WHONET: removing obstacles to the full use of information about antimicrobial resistance", Diagn Microbiol Infect Dis, 25, pp.162~168 (1996)
7. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty fourth Informational supplement, M100-S24", Clinical and Laboratory Standards Institute, ~ (2014)
8. 이혁민, "2004년도 국내 12개 병원에서 분리된 주요 세균의 항균제 내성율", Annals of Clinical Microbiology, 8(1), pp.66~73 (2005), 대한임상미생물학회
9. 이혁민, "2005∼2006년 국내 12개 병원에서 분리된 주요 세균의 항균제 내성률", Annals of Clinical Microbiology, 10(1), pp.59~69 (2007), 대한임상미생물학회
10. 케이고 시바야마, "Comparison of Antibiotic Resistance Rate of Medically Important Microorganisms between Japan and Korea", Annals of Clinical Microbiology, 18(4), pp.111~118 (2015), 대한임상미생물학회
11. "Antimicrobial resistance surveillance in Europe 2014" (2015)[URL]
12. "Japan Nosocomial Infections Surveillance (JANIS); Annual Open Report" (2014)[URL]
13. Barnes SL, "Preventing the transmission of multidrug-resistant organisms: modeling the relative importance of hand hygiene and environmental cleaning interventions", Infect Control Hosp Epidemiol, 35, pp.1156~1162 (2014)
14. Kim MK, "Discrepancy in perceptions regarding patient participation in hand hygiene between patients and health care workers", Am J Infect Control, 43, pp.510~515 (2015)
15. Choi SH, "Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 clinical and laboratory standards institute penicillin breakpoints", Antimicrob Agents Chemother, 56, pp.4650~4655 (2012)
16. 김혜인, "A 2011-2012 Survey of Doctors’ Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia", Infection and Chemotherapy, 45(4), pp.394~405 (2013), 대한감염학회[DOI]
17. 이희주, "2003∼2007년 한 대학병원 혈액배양에서 분리된 장알균의 항균제 저항성 및 Vancomycin 내성 장알균 균혈증에 관여하는 위험인자 분석", Annals of Clinical Microbiology, 13(2), pp.59~67 (2010), 대한임상미생물학회
18. Kang CI, "Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study", Eur J Clin Microbiol Infect Dis, 33, pp.55~59 (2014)
19. Jung MK, "Molecular epidemiology of vancomycin-resistant enterococci isolated from non-tertiary-care and tertiary-care hospitals in Korea", Epidemiol Infect, 142, pp.2372~2377 (2014)
20. Boucher HW, "Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus", Clin Infect Dis, 45, pp.601~608 (2007)
21. Park SH, "Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15", BMC Infect Dis, 12, pp.149~ (2012)
22. Jeon JH, "Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high", Antimicrob Agents Chemother, 56, pp.3043~3046 (2012)
23. Jacoby GA, "Mechanisms of resistance to quinolones", Clin Infect Dis, 41(S2), pp.S120~S126 (2005)
24. Yang HY, "Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumonia isolated from blood cultures in Korea", Can J Infect Dis Med Microbiol, 25, pp.163~169 (2014)
25. Lee K, "Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea", Microb Drug Resist, 12, pp.44~49 (2006)
26. Seok Y, "Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea", J Antimicrob Chemother, 66, pp.2791~2796 (2011)
27. Yong D, "Increasing prevalence and diversity of metallo-beta-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea", Antimicrob Agents Chemother, 50, pp.1884~1886 (2006)
28. Yano H, "Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem", Antimicrob Agents Chemother, 45, pp.1343~1348 (2001)
29. Lee Y, "Increasing prevalence of blaOXA-23-carrying Acinetobacter baumannii and the emergence of blaOXA-182-carrying Acinetobacter nosocomialis in Korea", Diagn Microbiol Infect Dis, 77, pp.160~163 (2013)
30. Kuo LC, "Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome", Clin Microbiol Infect, 13, pp.196~198 (2007)
31. Prasad P, "Excess deaths associated with tigecycline after approval based on noninferiority trials", Clin Infect Dis, 54, pp.1699~1709 (2012)

관련 논문AI추천